Sign inGet started

Howarth Alex G.

Insider CIK 1795798 · MDGL Chief Financial Officer · AKCA Chief Operating Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MDGL MADRIGAL PHARMACEUTICALS, A Award deriv2024-01-232024-01-257,238— $07,238SEC↗
MDGL MADRIGAL PHARMACEUTICALS, A Award deriv2024-01-232024-01-254,803— $04,803SEC↗
MDGL MADRIGAL PHARMACEUTICALS, A Award2024-01-232024-01-254,803— $018,737SEC↗
MDGL MADRIGAL PHARMACEUTICALS, F Tax w/h2024-01-162024-01-181,067$243.92 $260.3K13,934SEC↗
MDGL MADRIGAL PHARMACEUTICALS, A Award2023-01-162023-01-1815,001— $015,001SEC↗
MDGL MADRIGAL PHARMACEUTICALS, A Award deriv2022-02-222022-02-2445,000— $045,000SEC↗
MDGL MADRIGAL PHARMACEUTICALS, A Award deriv2021-11-012021-11-035,000— $05,000SEC↗
MDGL MADRIGAL PHARMACEUTICALS, A Award deriv2021-05-172021-05-1965,000— $065,000SEC↗
AKCA AKCEA THERAPEUTICS, INC. D To issuer deriv2020-10-122020-10-1334,200$5.39 $184.3K0SEC↗
AKCA AKCEA THERAPEUTICS, INC. D To issuer deriv2020-10-122020-10-13300,000$0.21 $63.0K0SEC↗
AKCA AKCEA THERAPEUTICS, INC. U Tender2020-10-122020-10-1366,800$18.15 $1.21M0SEC↗
AKCA AKCEA THERAPEUTICS, INC. A Award deriv2020-03-192020-03-2334,200— $034,200SEC↗
AKCA AKCEA THERAPEUTICS, INC. A Award2020-03-192020-03-2316,800— $066,800SEC↗
AKCA AKCEA THERAPEUTICS, INC. A Award deriv2019-12-022019-12-04300,000— $0300,000SEC↗
AKCA AKCEA THERAPEUTICS, INC. A Award2019-12-022019-12-0450,000— $050,000SEC↗